These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 7617649
1. Preferential reduction of nm23-H1 gene product in metastatic tissues from papillary and follicular carcinomas of the thyroid. Arai T, Yamashita T, Urano T, Masunaga A, Itoyama S, Itoh K, Shiku H, Sugawara I. Mod Pathol; 1995 Apr; 8(3):252-6. PubMed ID: 7617649 [Abstract] [Full Text] [Related]
2. Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid. Arai T, Watanabe M, Onodera M, Yamashita T, Masunaga A, Itoyama S, Itoh K, Sugawara I. Am J Pathol; 1993 Jun; 142(6):1938-44. PubMed ID: 8389529 [Abstract] [Full Text] [Related]
3. Nm23 protein expression in thyroid neoplasms. Royds JA, Silcocks PB, Rees RC, Stephenson TJ. Pathologica; 1994 Jun; 86(3):240-3. PubMed ID: 7808792 [Abstract] [Full Text] [Related]
4. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Mandai M, Konishi I, Koshiyama M, Mori T, Arao S, Tashiro H, Okamura H, Nomura H, Hiai H, Fukumoto M. Cancer Res; 1994 Apr 01; 54(7):1825-30. PubMed ID: 7907945 [Abstract] [Full Text] [Related]
5. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis. Viel A, Dall'Agnese L, Canzonieri V, Sopracordevole F, Capozzi E, Carbone A, Visentin MC, Boiocchi M. Cancer Res; 1995 Jun 15; 55(12):2645-50. PubMed ID: 7780979 [Abstract] [Full Text] [Related]
8. The role of nm23-H1 in the progression of transitional cell bladder cancer. Chow NH, Liu HS, Chan SH. Clin Cancer Res; 2000 Sep 15; 6(9):3595-9. PubMed ID: 10999750 [Abstract] [Full Text] [Related]
9. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables. Tannapfel A, Katalinic A, Köckerling F, Wittekind C. Am J Gastroenterol; 1997 Jul 15; 92(7):1182-6. PubMed ID: 9219795 [Abstract] [Full Text] [Related]
14. [Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer]. Huang Y, Cai S, Yu S. Zhonghua Fu Chan Ke Za Zhi; 1997 Dec 15; 32(12):718-21. PubMed ID: 9772433 [Abstract] [Full Text] [Related]
16. Expression of antimetastatic gene nm23-H1 in epithelial ovarian cancer. Qian M, Feng Y, Xu L, Zheng S, Zhou X. Chin Med J (Engl); 1997 Feb 15; 110(2):142-4. PubMed ID: 9594287 [Abstract] [Full Text] [Related]
17. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma. Iizuka N, Oka M, Noma T, Nakazawa A, Hirose K, Suzuki T. Cancer Res; 1995 Feb 01; 55(3):652-7. PubMed ID: 7530600 [Abstract] [Full Text] [Related]
18. [The correlation between lung cancer lymph node metastasis and nm23-H1 gene mutation, mRNA expression]. Wang G, Du C, Lin Q. Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec 01; 20(6):340-3. PubMed ID: 10374442 [Abstract] [Full Text] [Related]
19. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma. Gazzeri S, Brambilla E, Negoescu A, Thoraval D, Veron M, Moro D, Brambilla C. Lab Invest; 1996 Jan 01; 74(1):158-67. PubMed ID: 8569178 [Abstract] [Full Text] [Related]
20. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma. Zafon C, Obiols G, Castellví J, Tallada N, Galofré P, Gemar E, Mesa J, Simó R. J Clin Endocrinol Metab; 2001 Aug 01; 86(8):3975-80. PubMed ID: 11502841 [Abstract] [Full Text] [Related] Page: [Next] [New Search]